Prof Param Mariappan FRCS(Urol), PhD
@ParamMariappan
Followers
1K
Following
9K
Media
257
Statuses
3K
Consultant Urological Surgeon | Director Edinburgh Bladder Cancer Surgery @EdinSurg_BC | @Uroweb Bladder Cancer Guideline panels | Golfer. Views my own
Edinburgh, United Kingdom
Joined April 2019
Let’s Fight Bladder Cancer, Scotland! @BladderCancerUK @NHS_Lothian @NHS_HS #BladderCancer #BladderCancerAware
2
9
55
If you are keen on understanding the evolving landscape of therapies for #bladdercancer, look no further than this video. Packed w impt insights on upcoming & ongoing P3 trials. @uromigos @brian_rini @tompowles1
After the success of Disitamab Vedotin plus toripalimab in bladder cancer #ESMO25 we asked what other randomised trial are ongoing in China 🇨🇳 ? In this Uromigos Short Dr Yige Bao describes a number of new RIII studies #uromigoslive @oncoalert
0
3
6
Assessing baseline bladder function for patients considering trimodal therapy. Comron Hassanzadeh, MD, MPH joins @UroDocAsh to discuss emerging comprehensive bladder toxicity measurement tools. The discussion covers technical advances, including IMRT optimization to reduce
0
5
18
It was great to see so many Scottish trainees attend the #UpperTract teaching day @rcpsglasgow. Enthusiastic and very well read. Great talks from everyone involved, including @tsoburol and Consultant colleagues from across #Scotland
1
1
11
Honored to debate TURBT vs. En Bloc Resection with @jteoh_hk at #B2BGUCancersTriad during @SIU_urology Congress #SIU2025Edinburgh 🎤💥 Proud to advance innovation, quality, and safety in #BladderCancer care. Grateful to share this global stage 🌍 @UTMBUrology @UTMBPresident
2
6
28
📣 T–48h until the 7th #B2BGUCancersTriad kicks off at #SIU2025Edinburgh! Join us for this full-day programme dedicated to the latest breakthroughs in prostate, bladder, and kidney cancers. 🧬🌍 🔬 What to expect: ✅ Expert-led panel discussions on emerging therapies and
0
1
9
Huge congrats to @tompowles1 on shifting the paradigm in #bladdercancer (& frankly #cancer at large) w #IMvigor011, paving the way ctDNA as a tool for potentially allocating #adjuvant therapy. Bravo also on the simultaneous @NEJM publication!
0
31
77
📣 Mark your calendars for the #SIU2025Edinburgh luncheon symposium: Advancing NMIBC Management: From Clinical Evidence to Daily Practice. Join Dr Peter Black, Prof Jeremy Teoh, Prof Paolo Gontero, Prof Param Mariappan and Dr Vikram Narayan for this in-depth and informative
0
4
8
🧵 1/ Proud to finally share a paper that took a great deal of effort to write and get published. A global survey sent to 600+ uro-oncologists, with 201 responses from over 30 countries, exploring real-world use of enfortumab vedotin + pembrolizumab (EV-P) in metastatic
3
21
45
Too many patients continue to share stories about misdiagnosis, delays in diagnosis, and not taking #BladderCancer symptoms seriously. This has to change. We’re doing everything we can to raise awareness of this forgotten cancer. Will you help us by sharing this post?
0
6
4
Terrific talk by @AlbigesL @GustaveRoussy related to #biomarkers in #kidneycancer that spanned #KIM1, #microbiome (MAdCAM-1, TACITO), #sarcomatoid histology, #NLR & so much more. Particularly enjoyed the discussion around #PDL1 - she laid out excellent rationale for #CARE1! Very
2
12
23
Day2⃣of #IUCS25 🇬🇧Portsmouth Dr. Petros Grivas🇺🇸 discusses “How Perioperative Treatment is Evolving in Bladder Cancer.” 🔹 NIAGARA trial: Cisplatin-based chemo + durvalumab = practice-changing for cisplatin-fit patients 🔹 Cisplatin eligibility still based on Galsky criteria
0
9
15
I am so happy to sit between amazing people & getting smarter by osmosis! Wonderful meeting! @urologysummit @OncoAlert @montypal @neerajaiims @DrYukselUrun @gbanna74 @ravikanesvaran @ParamMariappan @alison_tree @fredhutch @AlbigesL
@drenriquegrande @eaonc @IBCG_BladderCA
Listening with full attention. #IUCS25
@urologysummit @gbanna74 @ravikanesvaran @OncoAlert @ONCOassist @neerajaiims @PGrivasMDPhD @drenriquegrande @montypal @nataliagandur @alison_tree @ManiamAkash @Ecastromarcos @amg120395
0
5
19
A GREAT START TO #IUCS25 🇬🇧in Portsmouth as REPORTED by MedTrack Social @OncoReporte
https://t.co/TIbQPhoKrQ USE MEDTRACK, its Free & Available for all Made by Colleagues, for Colleagues⚕️ @neerajaiims
@montypal
@DrYukselUrun
@yekeduz_emre
@bavilima
@weoncologists
0
12
14
Phase 3 KEYNOTE-905 (EV-303) trial in cisplatin-ineligible patients with MIBC reports improvement in EFS, OS and pCR rates with perioperative EV+Pembro @MattGalsky @tompowles1 @PGrivasMDPhD @shilpaonc @IBCG_BladderCA @BladderCancerUS @JoshMeeks @LauraBukavinaMD @UrogerliMD
0
10
31
@IBCG_BladderCA @UroDocAsh @BladderCancerUS @WorldBladderCan @LauraBukavinaMD @shilpaonc @UrogerliMD @pjhensley11 @AmandaMyersMD @bavilima @JoshMeeks @siadaneshmand @AndreaNecchi @emanuele_crupi @karima_oualla @h_alahmadie @ParamMariappan @spsutkaMD @NehaVapiwala @koshkin85
As we get ready for #IBCG25, we’d like to welcome our new members - bringing fresh perspectives, expertise, and energy to our global mission. Your voices and vision will help shape the future of bladder cancer care through collaboration, innovation, and shared purpose. Welcome!
0
2
13
No time to waste—we need to start cancer clinical trials faster https://t.co/oaGF7tdXTN
bmj.com
Cancer clinical trials in the UK are at a critical juncture. They face significant systemic pressures within the NHS and regulatory pathways that threaten efficiency and timeliness. Both commercial...
0
3
7
A warm invite to all of our GU Colleagues to attend IN PERSON OR ONLINE (HYBRID) To the International Urology Cancer Summit🇬🇧 in Portsmouth!! REGISTER HERE👉 https://t.co/H3PxvHLfe0 The International Urology Cancer Summit is a FREE, independent educational event for all
0
10
15
Societie International d'Urologie (SIU) is a urological society with more than 17,000 members from over 130 countries globally. This year, the SIU Congress will be held in Edinburgh from 29th October to 1st November. Registration link: https://t.co/iLk3Ss3Wcj
2
6
24
J&J receives @US_FDA Priority Review for TAR-200 in high-risk NMIBC Phase 2b SunRISe-1 study #AUA25 ✅82.4 % CR rate ☑️ 52.9 % cancer-free at least one year after CR https://t.co/jMtTd90T7x
2
25
81
🚨Applications now open for the 25/26 Robotic Pelvic Oncology (Bladder Cancer) Fellowship @CUH_NHS Join a high volume cystectomy team, train in robotics and get involved in research! Apply below👇🏽 @aw_nelson @AlexandraColqu2
careers.cuh.nhs.uk
0
5
15